Unicycive Therapeutics: Addressing a $2.5 Billion Global Market Opportunity in Kidney Disease
1 year ago
A biotech dedicated to developing treatments for unmet medical needs, Unicycive Therapeutics (NASDAQ: UNCY) is currently advancing two programs focused on kidney disease and intends to expand its pipeline to target additional indications within and outside kidney disease. Unicycive is preparing to commercialize and launch its lead therapy, Renazorb, for treatment of hyperphosphatemia in patients with chronic kidney disease and is continuing development of UNI 494 for treatment of acute kidney injury. Visit UNCYinfo.com to learn more.
Loading comments...
-
0:29
RedChip
1 year agoUnicycive Therapeutics: Advancing Breakthroughs in Kidney Disease Therapies
-
3:02
1AESidneyAndBard
1 year agoDiscover the Secret to Healthy Kidneys: The Kidney Disease Solution
33 -
27:38
redbubblespreadshop
1 year agoThe Chronic Kidney Disease Breakthrough: Say Goodbye to Dialysis
111 -
27:38
1AESidneyAndBard
1 year agoThe Chronic Kidney Disease Miracle: How to Improve Your Kidney Function Naturally
14 -
2:34
Matthew Lennon Healer @ World Healing Centre
10 months agoChronic Kidney Disease
33 -
0:29
FGP
6 months ago🌐 Guarding Kidney Health: Early Detection Matters🩺
68 -
1:51:52
TheRealTruthAboutHealth
7 months agoPlant-Based Kidney Protection Made Easy-Whole Patient Strategies, CKD To Dialysis
194 -
1:06
Cryptostreets
2 months agoMini Kidneys Uncover Big Advances in Polycystic Kidney Disease Research
27 -
2:11
One4AllChannel
1 year agoI Used To Suffer Chronic Kidney Disease
7 -
5:33
Biological Medicine
9 months agoChronic kidney disease and how to improve your kidney health
5941